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C ell and gene therapies are destined to transform the methods by which global healthcare challenges are approached and overcome (1). The US Food and Drug 
Administration is reviewing and approving an 
increasing number of cell and gene therapy products 
(2), and biopharmaceutical developers are dedicating 
immense resources to realizing the enormous 
potential of these therapeutics. Therefore, 
technologies that facilitate their effective and 
efficient manufacture will accelerate cell and gene 
therapies’ transition from medicines of the future to 
medicines of the present (3). 
Cell therapies are administered as live cells from a 
patient (autologous) or donor (allogeneic) for 
therapeutic benefit (e.g., blood transfusions and stem-
cell therapy). Gene therapies can be considered as the 
addition, silencing, correction, or reprogramming of 
genetic material through application of vectors for 
therapeutic benefit (e.g., Luxturna voretigene 
neparvovec-rzyl from Spark Therapeutics for inherited 
retinal RPE65 gene disease) (4).
Cell and gene therapies require extracting and 
selecting autologous or allogeneic cells, then 
transforming them to a final product that is 
therapeutically advantageous (Figure 1a). 
Transformed material is expanded ex vivo and 
readministered for therapeutic benefit. Chimeric 
antigen receptor (CAR) T-cell therapies are examples 
of cell and gene therapies. They are developed by 
reprograming immune cells to target cancer cells. 
The FDA has approved two CAR T-cell therapies: 
Kymriah (tisagenlecleucel) from Novartis and 
Yescarta (axicabtagene ciloleucel) from Kite Pharma 
for the treatment of B-cell acute lymphoblastic 
leukemia and relapsed or refractory large B-cell 
lymphoma, respectively (5, 6). 
Bioreactors provide the growth conditions 
required to increase cells and vectors to quantities 
sufficient for therapeutic doses. The vessels provide 
a sterile environment for eukaryotic or microbial 
culture conditions (e.g., temperature, aerobic/
anaerobic, and pH), with the addition of nutrients 
(e.g., carbohydrates, proteins, and lipids) and growth 
factors (e.g., cytokines), which typically are 
monitored extracellularly (7). Extracellular 
measurements provide an excellent indication of 
cell-culture inputs and outputs. However, they do not 
provide a direct indication of subcellular processes, 
which are where many biochemical changes 
important for effective cell culture occur (Figure 1b). 
Therefore, the introduction of tools that permit real-
time analytics of subcellular biochemical processes 
could play a significant role in the optimization of 
cell and gene therapy manufacturing and facilitate 
the transition of these products to mainstream 
therapeutics. 
Background
Fluorescent nanosensors are emerging technologies 
that permit silent measurement of key biochemical 
parameters to high spatial and temporal resolution 
(8). Nanosensors can be manufactured to a range of 
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Figure 1: (a) Cell and gene therapy development 
pathway from patient/donor (red) to recipient (blue);  
(b) subcellular molecules and ions important for 
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sizes, from 10 nm to 1,000 nm in diameter (9). They 
are manufactured from inert biocompatible 
materials (10) that bind to or encapsulate 
fluorophores (Figure 2a). 
Fluorescent nanosensors typically consist of two 
or more different fluorophores that are reference and 
analyte-sensitive entities. A reference fluorophore 
produces a stable fluorescence emission upon 
excitation, which is insensitive to an analyte of 
interest. An analyte-sensitive fluorophore exhibits a 
dynamic fluorescence emission dependent on the 
amount of target. Multiple targets can be detected by 
incorporating more than one analyte-sensitive 
fluorophore (11). The combination of reference and 
analyte fluorophores enables accurate ratiometric 
measurements (12). 
Fluorescence techniques have a greater sensitivity 
than do other spectroscopic methods. Therefore, 
nanosensors can be delivered at subharmful 
concentrations and accurately report subcellular 
biochemical processes through the control of input 
excitation only (13). Fluorescent nanosensors have 
been reported for the “A to Z” of analytes, from 
adenosine triphosphate (ATP) to zinc, and research 
in this exciting field continues to advance (14–16). 
My group’s research focuses on nanosensors 
relevant to cell and gene therapies. They are for pH 
(H+) (12) and molecular oxygen (O2) (17) and 
manufactured from inert polyacrylamide matrices. 
These nanoparticles (~50 nm in diameter) have been 
engineered to traverse biological membranes to 
observe and induce biochemical changes. Our 
research also has been extended to observe whole-
organism bioprocesses. 
Subcellular Analytics
Noninvasive targeted subcellular delivery can be 
considered as the zenith of formulation sciences. That 
is because cell membranes act as physical barriers, 
and programed cellular inertia prevents entry of 
unknown systems. Research has focused on reducing 
the effect of membrane barriers (18) using heat shock 
(19), surfactant treatment (20), electroporation (21), 
and changes in osmolarity (22). Other methods 
include accessing known cell-receptor internalization 
(e.g., clathrin mediated) (23) and using forced entry 
(e.g., gene-gun delivery) (24). As such, delivery of 
diagnostics tools such as fluorescent nanosensors has 
been challenging.
In my group’s strategy, we functionalized 
fluorescent nanosensors matrices with cationic 
molecules (Figure 2b–d). Cationic molecules increase 
the zeta potential of nanoparticle surfaces, which has 
been hypothesized to facilitate nanoparticle 
penetration between hydrophobic moieties of lipid 
bilayers and cause membrane disruption at high 
concentrations (25). When we control the amount of 
positive functionalized monomer and nanoparticle 
concentrations, nanosensors can traverse multiple 
biological membranes and silently report on key 
biochemical changes. In separate studies, we have 
demonstrated how fluorescent nanosensors can be 
used to characterize subcellular environments for 
Saccharomyces cerevisiae (26) and human 
mesenchymal stem cells (hMSCs) (27, 28).
S. cerevisiae has been implemented as an animal-
free alternative to using adenoassociated viruses 
(AAVs) as vectors for gene therapies (29). S. cerevisiae 
comprises both a cell wall and membrane. The cell 
wall acts as an additional physical barrier to 
Figure 2: (a) Ratiometric fluorescent nanosensors; (b) delivery to Saccharomyces cerevisiae (26) and human 
mesenchymal stem cells (hMSCs) (27) for (c) determining intracellular processing of silica magnetic iron nanoparticles 
and (d) photo induced phenotypic changes (28) as well as (e) pharyngeal and intestinal pH mapping in Caenorhabditis 
elegans 
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nanoparticle delivery. Our research has shown that 
by engineering polyacrylamide-based nanoparticles 
with the cationic molecule acrylamidopropyl 
trimethyl ammonium hydrochloride (ACTA), we 
demonstrated significant improvements in 
subcellular delivery without obvious changes to S. 
cerevisiae viability when compared with 
unfunctionalized particles (26). 
We also have shown that fluorescent nanosensors 
can be used to study the influence of adding carbon 
sources in the form of sugars such as glucose on 
intracellular pH. Addition of glucose to S. cerevisiae 
results in an initial decrease in subcellular pH (after 
10 minutes). Subcellular pH recovers to preglucose 
dose levels after 30 minutes. This research could be 
translated readily to improve AAV development and 
manufacturing by optimizing carbon-dose cycles and 
media replenishment. 
 hMSCs have been the focus of immense clinical 
research for their application in cell therapies and 
regenerative medicine (30). They can differentiate 
into multiple cell types and replenish their own 
stem-cell stores (31). Because of their ease of 
extraction, isolation, and expansion, hMSCs have 
been used in clinics for treating blood and bone 
marrow cancers. Through advances in their 
biomanufacturing, their full potential could be 
realized (32). Research we have conducted has shown 
how pH-sensitive nanosensors can be used to 
monitor the degradation of tools used to facilitate 
targeted delivery of hMSCs (27) and how light-
induced irradiation of internalized nanoparticles 
could be used to induce biochemical changes and 
consequential cell differentiation (28).
Silica magnetic-iron nanoparticles (SiMAGs) have 
been studied for their potential in direct hMSC 
therapy by using magnetism to facilitate targeted 
therapy (33). However, the challenges with this 
strategy are understanding how SiMAGs are 
processed subcellularly and determining whether 
they permit long-term magnetic manipulation. Our 
research investigated whether pH-sensitive 
fluorescent nanosensors could address those 
challenges when combined with state-of-the-art 
technologies such as super-resolution fluorescence 
microscopy and multicolor flow-cytometric analysis 
(Figure 2c) (27). Super-resolution fluorescence 
microscopy confirmed that pH-sensitive 
nanosensors are colocalized with SiMAGs in 
lysosomal–endosomal spaces and permit long-term 
measurement. Flow cytometry was implemented to 
determine qualitatively and quantitatively the 
influence of SiMAGs on intracellular pH for seven 
days. Our analyses suggest that SiMAGs reduce 
intracellular pH over four days (from pH 5.43 ± 
0.06 to 4.81 ± 0.14), which corresponds to SiMAG 
subcellular processing. The pH recovers to pre-
SiMAG dosage levels on day 6 (pH 5.33 ± 0.17). Our 
studies suggest that SiMAG lysosomal–endosomal 
pathway exposure degrades both fluorescent silica 
coatings and iron cores, reducing cell loading by no 
more than 50% over seven days. That reduction in 
subcellular SiMAG concentration still would allow 
long-term magnetic manipulation of hMSCs. 
Controlled changes in biochemical processes that 
produce predifferentiation of hMSCs in vitro afford 
the prospect of improvements in regenerative 
efficacy in vivo (34). Our research has shown that 
controlled changes in subcellular hMSC biochemical 
processes can be achieved through light-induced 
generation of reactive oxygen species (ROS), using 
photoactivatable porphyrins attached to 
polyacrylamide nanoparticles (Figure 2d) (28). 
Through control of either the concentration of 
photoactivatable porphyrins or number of light 
irradiations, the amount of ROS produced can be 
regulated. We used a newly synthesized fluorophore 
to identify ROS generation events through increases 
in emission intensity. Cytokine analyses, with flow 
cytometric analysis, indicated light-irradiation–
induced controlled apoptotic cell death, rather than 
uncontrolled necrotic cell death. Our experiments 
contribute to the development of light-induced 
differentiation of hMSCs for clinical translation 
in vitro and for whole-organism analyses.
Whole-Organism Analyses
The potential of fluorescent nanosensors can be 
demonstrated when they are used to determine 
real-time in situ analytics for complex bioprocesses 
in living organisms such as Caenorhabditis elegans 
(Figure 2e). C. elegans is a free-living soil nematode 
and the most completely understood animal on the 
planet in terms of genetics, neurology, and cell 
survival. Its application as a model in the study of 
complex biochemical processes has gathered 
significant momentum. That is because C. elegans is 
easy to culture (feeds on bacterial lawns on agar 
plates), has a short lifecycle (egg to adult in three 
days), is optically transparent (permits optical 
visualization of anatomical events), and has freely 
available mutants that could function as 
experimental controls. In addition, because 
C. elegans nematodes are invertebrates, they do not 
require ethical approval to conduct research. 
Therefore, they are an extremely useful model 
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organism in research that combines complex biology 
such as cell and gene therapy and bioanalytical 
tools such as fluorescent nanosensors (35).
Our research has shown that pH-sensitive 
nanosensors can be delivered to C. elegans pharyngeal 
and intestinal lumen to make measurements (36). C. 
elegans can be fed nanosensors continually at 
relatively high concentrations for extended periods in 
the absence of significant toxicity. Furthermore, 
nanosensors remain in the C. elegans pharyngeal and 
intestinal lumen in excess of 24 hours after the 
challenge has been removed. These findings highlight 
the inert nature of fluorescent nanosensors and their 
potential to silently report biochemical changes for 
extended periods. Measurements of pharyngeal and 
intestinal pH show that C. elegans acidifies ingested 
matter such that there is pH gradient from the 
anterior of the pharynx (5.96 ± 0.31) to the posterior 
of the intestine (3.59 ± 0.09). Using high-speed 
fluorescence microscopy and temperature control to 
reduce the feeding rate, studies have shown that 
dynamic acidification of intestinal contents can be 
mapped in real time. These findings suggest that, 
under optimized conditions, fluorescent nanosensors 
could be used to monitor the efficacy of cell and gene 
therapies in situ. 
Future Perspective 
Fluorescent nanosensors are an extremely powerful 
tool and have been used to perform inert, long-term 
high spatial and high temporal measurements in a 
number of model organisms (8). However, it is 
important to note that the applications of fluorescent 
nanosensors to cell and gene therapies are in the 
early stages, and the true potential is yet to be 
determined. The tangible benefits of this technology 
to cell and gene therapies will be realized when 
measurements of key subcellular molecules and ions 
demonstrate advantages over extracellular 
measurement technologies that are essential to 
biomanufacturing (e.g., time lags and analysis of 
biochemical processes that occur only subcellularly). 
Nevertheless, fluorescent nanosensors’ enhanced 
measurement capabilities indicate a strong potential  
to characterize complex biochemical processes 
upstream, downstream, and in situ for cell and gene 
therapy manufacture. Furthermore, through the 
introduction of a new wave of analytical biosensors 
(37) — which have biodegradable polymeric matrices  
(38) — advanced production methods (39), and 
coupled innovative analytical instruments, 
fluorescent nanosensors are well positioned to 
enrich biomanufacturing for cell and gene therapies.
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